Vibeke Strand MD

Physician

306 Ramona RoadPortola Valley, CA 94028
Phone+1 650-400-2073

Dr. Strand is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Strand's full profile Already have an account?

Summary

Dr. Vibeke Strand is based in Portola Valley, CA, and specializes in rheumatology. She graduated from the University of California San Francisco School of Medicine and completed her residency in Internal Medicine at Michigan State University, Fellowship at UCSF. Currently an Adjunct Clinical Professor at Stanford University School of Medicine, she has extensive experience in lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, and other rheumatic conditions. Dr. Strand has been a consultant in clinical development including frequent interactions with FDA since 1991 and held prior positions, including 6 years in rheumatology private practice in San Francisco and 6 years ih clinical development in biotech companies, including Senior Director of Clinical Research at Xoma Corporation. She has numerous publications in reputable journals and has been recognized with honors such as MACR from the American College of Rheumatology. Dr. Strand has also contributed to clinical trials, including studies on treatments for knee osteoarthritis.

Education & Training

Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1978 - 1979
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1976 - 1978
University of California San Francisco School of MedicineClass of 1976
Swarthmore CollegeB.A., Zoology & Sociology/Anthropology, Honors, 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1979 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

MACR, Master of the American College of Rheumatology ACR, 2015
FACP, Fellow of the American College of Physicians ABIM, 1982
Who's Who in Science and Engineering 1982

Clinical Trials

Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA
COMPLETED
NA

Publications & Presentations

PubMed

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network...
Tommy K Annfeldt, Mina N Händel, Tobias Haugegaard, Marius Henriksen, Laura C Coates
Annals of the Rheumatic Diseases. 2026-08-01
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder in...
Dorthe B Berthelsen, Ben Horgan, Lee Simon, John P A Ioannidis, Niti Goel
Seminars in Arthritis and Rheumatism. 2026-08-01
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomiz...
Roy M Fleischmann, Vibeke Strand, Eugen Feist, Tatiana Lisitsyna, Jeffrey A Sparks
Rheumatology and Therapy. 2026-08-01

Journal Articles

Health-Related Quality of Life in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomised Controlled Trial
Micki Klearman, Vibeke Strand, John H Stone, BioMed Central
Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus: 6 Years of Treatment
Vibeke Strand, MD, Arthritis Care & Research
Blood Concentrations of Complement Split Product iC3b and Serum C3 Associate with SLE Disease Activity
Deepali P Sen, John P Atkinson, Vibeke Strand, Arthritis & Rheumatology

Other

Functional Impairment Measurement in Psoriatic Arthritis: Importance and Challenges
Vibeke Strand, MD, Seminars in Arthritis & Rheumatism
https://www.doximity.com/articles/09f8e5df-563f-4b90-b4e7-20086edbdd5c
UpToDate, Wolters Kluwer Health - 2012-04-18

Authored Content

Functional Impairment Measurement in Psoriatic Arthritis: Importance and ChallengesMay 2018

Press Mentions

Reproductive Health, Biosimilars & More in Focus at SOTA 2025January 30th, 2025
Biosimilars for Immune-Mediated Inflammatory Diseases – a Managed Care PerspectiveNovember 1st, 2022
Provider and Patient Knowledge Gaps on Biosimilars: Insights from SurveysNovember 1st, 2022